EUVIMEDEUVIMED entdecken
Multizentrische Studie

Circulating levels of ghrelin and hyperphagia in patients with rare genetic neurodevelopmental disorders

Gwenaëlle Diene iD, Grégoire Benvegnu iD, Cathy Brochado, Alice Clerc, Béatrice Jouret, Emilie Montastier iD, Solange Grunenwald iD, Christine Poitou iD, Delphine Heron iD, Vincent des Portes iD, David Cohen, Angèle Consoli und 5 weitere

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgag081 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Gwenaëlle Diene und 16 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Référence "SPW et autres syndromes avec troubles du comportement alimentaire (PRADORT)", Centre Hospitalier Universitaire de Toulouse, Toul…. Hauptthemen laut MEDLINE: Ghrelin, Hyperphagia, Prader-Willi Syndrome, Neurodevelopmental Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Millendo Therapeutics, Filière DéfiScience.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Hyperphagia, overweight, and obesity are frequent in people with rare neurodevelopmental disorders (NDDs). Prader-Willi syndrome (PWS) is a rare NDD with hyperphagia and hyperghrelinemia.

Objectives

To measure ghrelin levels, hyperphagia and caregiver burden in rare NDDs patients to understand pathophysiology and improve care.

Design

A single-visit, noninterventional, national, multicenter, cross-sectional study.

Setting

Seven French reference centers for rare NDDs participated. Patients A total of 130 patients (43% children) with a rare genetic NDD (27 distinct conditions) were included. Their median age was 19.8 years. Three control groups were used for comparison: “PWS” (n = 153), “Obese” (n = 49), and “Lean” (n = 31) groups. Main outcome measure(s) The primary endpoint was ghrelin level (total, acylated, unacylated). The first secondary endpoint was hyperphagia questionnaire (HQ) scores.

Results

Median total ghrelin levels were 76.7 (22.2-1110.9) pg/mL; median acylated levels were 33.7 (8.0-754.3) pg/mL; and median unacylated levels were 44.2 (11.5-356.6) pg/mL, which were lower than the PWS group (P < .001) and no different from the Obese group. The mean HQ total score was 26.3 (10-46) for children and 24.0 (11-52) for adults. The HQ total score was statistically higher in children with NDDs and lower in adults compared to PWS. The mean Zarit Burden Interview score was 37.8 (6-74) in children and 37.6 (2-76) in adults, and was positively correlated with the HQ total score.

Conclusion

Ghrelin levels were normal in our study population. Hyperghrelinemia is a biomarker of PWS. Hyperphagia is more prevalent and severe in children with NDDs compared with PWS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GhrelinHyperphagiaPrader-Willi SyndromeNeurodevelopmental DisordersHumansMaleFemaleCross-Sectional StudiesChildAdolescentAdultYoung AdultChild, PreschoolFranceObesity

Stichwörter der Autor:innen

Prader-Willi syndromecaregiver burdenghrelinhyperphagianeurodevelopmental disorders

Substanzen

Ghrelin

Autor:innen und Institutionen

  • Centre de Référence "SPW et autres syndromes avec troubles du comportement alimentaire (PRADORT)", Centre Hospitalier Universitaire de Toulouse, Toulouse 31300, France.
  • Axe Pédiatrique du CIC 9302/INSERM, Hôpital des Enfants, Toulouse 31300, France.
  • Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM, UMR1291-CNRS UMR5051-Université Toulouse III Paul Sabatier, Toulouse 31024, France.
  • Centre de Compétence "Maladies Rares à Expression Psychiatrique", Service Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Centre Hospitalier Universitaire de Toulouse, Toulouse 31300, France.
  • CERPOP (Centre d'Epidémiologie et de Recherche en santé des POPulations), UMR1295, INSERM-Université Toulouse III Paul Sabatier, Toulouse 31000, France.
  • Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), UMR1297, INSERM, Université Toulouse, Toulouse 31400, France.

ORCID-Profile: Gwenaëlle Diene, Grégoire Benvegnu, Emilie Montastier, Solange Grunenwald, Christine Poitou, Delphine Heron, Vincent des Portes, Caroline Demily, Lydie Burglen, Alexandra Afenjar, Maithé Tauber

Förderung

  • Millendo Therapeutics
  • Filière DéfiScience

Zitieren

APA

Diene, G., Benvegnu, G., Brochado, C., Clerc, A., Jouret, B., Montastier, E., Grunenwald, S., Poitou, C., Heron, D., des Portes, V., Cohen, D., Consoli, A., Demily, C., Burglen, L., Afenjar, A., Valette, M., & Tauber, M. (2026). Circulating levels of ghrelin and hyperphagia in patients with rare genetic neurodevelopmental disorders. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag081

Vancouver

Diene G, Benvegnu G, Brochado C, Clerc A, Jouret B, Montastier E, et al. Circulating levels of ghrelin and hyperphagia in patients with rare genetic neurodevelopmental disorders. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag081

BibTeX
@article{Diene2026,
  author = {Diene, Gwenaëlle and Benvegnu, Grégoire and Brochado, Cathy and Clerc, Alice and Jouret, Béatrice and Montastier, Emilie and Grunenwald, Solange and Poitou, Christine and Heron, Delphine and des Portes, Vincent and Cohen, David and Consoli, Angèle and Demily, Caroline and Burglen, Lydie and Afenjar, Alexandra and Valette, Marion and Tauber, Maithé},
  title = {Circulating levels of ghrelin and hyperphagia in patients with rare genetic neurodevelopmental disorders},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgag081}
}
Kostenlos starten →